explore -WSS

explore

author：explore 2025-09-30 20:46:50 - browse：59192

BRENDAN SMIALOWSKI/AFP via Getty Images

A New York jury on Wednesday convicted the former CEO of Stimwave, a company that sold devices with dummy pieces of plastic, on two counts of health care fraud. The maximum jail sentence for each count is 20 years.

Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. Under her leadership, Stimwave distorted the design of the device to better fit insurance codes, resulting in unnecessary plastic components that allowed the company to sell its products for thousands of dollars more than it otherwise could. From 2017 to 2020, the company sold nearly 8,000 devices with the non-functioning component.

STAT published new details about the Stimwave story last May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019. The fraud laid bare the limits of the Food and Drug Administration’s device surveillance system, doctors’ ability to scrutinize device effectiveness, and how impossible it is for patients to get answers about the implants they receive.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： MultiPlan and major insurers sued for alleged medical price

entertainment

WSS

Wegovy trial has doctors encouraged over new possibilities

Cholera vaccine supply gets boost as demand surges globally

How to use technology to prevent future drug shortages

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Cholera vaccine supply gets boost as demand surges globally

South Korea throws huge K

hotspot

explore

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Health care needs a new profession: neuroimaging counseling

BioMarin wins approval for gene therapy to treat hemophilia A

Why failed clinical trials don’t always spell doom for a new drug

Apple is now the first public company to be valued at $3 trillion

Maui's cultural, historic landmarks damaged in the devastating wildfires

BioMarin wins approval for gene therapy to treat hemophilia A

Dogs on Prozac: What pet anti

Trump demands the U.S. pay no more for drugs than other countries … again

In same hospitals, Black patients receive fewer opioids than white patients

knowledge

Drastic changes should bring profitability, startup health insurers say

Cholera vaccine supply gets boost as demand surges globally

Man killed during FBI raid in connection with threats against Biden, other officials

How to use technology to prevent future drug shortages

Anavex keeps shifting the goalposts in its clinical trials

FDA panel issues narrow recommendation for Covid vaccine booster doses

Wikipedia

entertainment

focus

entertainment